Banner
Home Fascicolo n.6/2005 Bibliografia
Bibliografia
Per un cuore idoneo...
pubblicato nel Novembre - Dicembre 2005 in Sport&Medicina - fascicolo n.6

Bibliografia

1. Bracchetti D, Naccarella F. Cuore e Sport, linee guida per l’idoneità all’attività sportiva agonistica. Traduzione italiana della 26a Bethesda Conference. Torino: Centro Scientifico Editore, 1999.

2. AA VV. Protocolli cardiologici per il giudizio di idoneità allo sport agonistico 1995. Roma: Casa Editrice Scientifica Internazionale, 1996.

3. AA VV. Protocolli cardiologici per il giudizio di idoneità allo sport agonistico 2003. Roma: Casa Editrice Scientifica Internazionale, 2004.

4. Naccarella F, Furlanello F, Bertoldi A et al. “Lone” atrial fibrillation in athletes: a consequence of long lasting intensive sport practice? In: Raviele A. Proceedings of the international congress on arrhythmias; 2003; Venezia. Berlino: Springer Verlag, 2004.

5. Naccarella F, Lepera G, Casotti A et al. La sindrome di Marfan e disordini correlati della fibrillina. Aspetti genetici e clinici con particolare riferimento alla pratica dello sport. Ita J Sport Cardiol 2003; 24: 356-69.

6. Liying C, Shu-Zheng L, Cappato R et al. Conduction recurrence across RF lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Proceedings of the Santini’s meeting; 2004. Bologna: Medimond, 2005.

7. Cappato R, Neuroni S, Pecora D et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation 2003; 108:1599-604.

8. Mark Estes III NA, Salem DN . Sudden cardiac death in the athlete. Armonk (NY): Futura Publishing Company, 1999.

9. Berul CI, Towbin JA. Molecular genetics of cardiac electrophysiology. Norwell (MA): Kluwer Academic Publishers, 2001: 1-378.

10. Mottram DR. Farmaci e sport. Milano: Casa editrice Ambrosiana, 2005: 1-460.

11. Furlanello F, Bertoldi A, De Ambroggi L et al. Illecit drugs and cardiac arrhythmias in athletes. MESPE Journal 2004; 2: 62-9.

12. Oto A, Breithard G, Myocardial repolarization from gene to bedside. Armonk (NY): Futura Publishing Company Inc, 2002.

13. Camm AJ, Malik M, Guan Yap Y, Acquired long QT syndrome. Oxford (UK): Blackwell Futura, 2004.

14. Nava A, Rossi L, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Amsterdam: Elsevier, 1997.

15. Zareba W, Maison-Blanche P, Locati E. Noninvasive electrocardiology in clinical practice. Armonk (NY): Futura Publishing Company Inc, 2002.

16. Zeppilli P. Cardiologia dello sport. 3a ed. Roma: Casa Editrice Scientifica Internazionale, 2002.

17. Elefteriades JA. Diseases of the aorta. Cardiol Clin 1999; 17: 1-855.

18. Bogaert J, Duerinckx AJ. Magnetic resonance of the heart and great vessels. Berlino: Springer, 2002.

19. Hoffmann E, Midiri M. Risonanza magnetica cardiovascolare. Napoli: Gnocchi Editore, 1996.

20. Moss AJ, Stern S. Noninvasive Electrocardiology: clinical aspects of holter monitoring. Londra: Sounders Company LTD, 1998.

21 Osterhues HH, Hombach V, Moss AJ. Advances in noninvasive 22. electrocardiographic monitoring techniques. Dordrecht: Kluwer Academic Publishers, 2002.

22. Lacro RV. Marfan syndrome and related disorders of fibrillin. In: Berul CI, Towbin JA. Molecular genetics of cardiac electrophysiology. Norwell (MA): Kluwer Academic Publishers, 2001.

23. Boudoulas H, Wooley CF. Mitral valve prolapse: floppy mitral valve, mitral valve prolapse, mitral valvular regurgitation. 2nd ed. Armonk (NY): Futura Publishing Company, 2001.

24. Sparks EH, Boudoulas H, Wooley CF. The floppy mitral valve in the Marfan Syndrome, in connective tissue disorders. In: Boudoulas H, Wooley CF. Mitral valve prolapse: floppy mitral valve, mitral valve prolapse, mitral valvular regurgitation. 2nd ed. Armonk (NY): Futura Publishing Company, 2001.

25. Le Marec H, Trochu JN, Schott JJ, Kyndt F, Benichou B. Mapping of a gene for a X linked myxomatous valvular disease. In: Boudoulas H, Wooley CF. Mitral valve prolapse: floppy mitral valve, mitral valve prolapse, mitral valvular regurgitation. 2nd ed. Armonk (NY): Futura Publishing Company, 2001: 191-209.

26. Schaal SF. Mitral valve prolapse: cardiac arrhythmias and correlates. In: Boudoulas H, Wooley CF. Mitral valve prolapse: floppy mitral valve, mitral valve prolapse, mitral valvular regurgitation. 2nd ed. Armonk (NY): Futura Publishing Company, 2001: 409-30.

27. Boudoulas H, Wooley CF. Floppy mitral valve prolapse/mitral valve prolapse: sudden death. In: Boudoulas H, Wooley CF. Mitral valve prolapse: floppy mitral valve, mitral valve prolapse, mitral valvular regurgitation. 2nd ed. Armonk (NY): Futura Publishing Company, 2001: 431-48.

28. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66.

29. Hwang C, Wu TJ, Doshi RN et al. Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation. Circulation 2000; 101: 1503-5.

30. Hindricks G, Kottkamp H. Simultaneous noncontact mapping of left atrium in patients with paroxysmal atrial fibrillation. Circulation 2001; 104(3): 297-303.

31. McGovern BA, Liberthson R. Arrhythmias induced by exercise in athletes and others. S Afr Med J 1996; 86 (Suppl 2): C78-82.

32 Zehender M, Meinertz T, Keul J et al. ECG variants and cardiac arrhythmias in athletes: Clinical relevance and prognostic importance. Am Heart J 1990; 119: 1378-94.

33. Biffi A, Piovano G, Verdile L et al. Prognostic evaluation on supraventricular arrhythmias in athletes. In: Pelliccia A, Caselli G, Bellotti P , eds. Advances in Sport Cardiology. Milano: Springer Verlag Italia, 1997: 40-4.

34. Delise P, Bonso A, Cor L et al. Electrophysiologic substrates of idiopathic atrial fibrillation in the general population and in athletes. New Trends Arrhyth 1992; 8: 719-24.

35. Coelho A, Palieo E, Ashley W et al. Tachyarrhythmias in young athletes. J Ambul Monit 1990; 3-4: 269-81.

36. Bertoldi A, Furlanello F, Fernando F et al. Cardioarrhythmologic evaluation of symptoms and arrhythmic manifestations in 110 top level consecutive professional athletes. New Trend Arrhytm 1993; 9: 199-209.

37. Furlanello F, Bettini R, Bertoldi A et al. Competitive sports and cardiac arrhythmias. In: Luderitz B, Saksena S , eds. International electrophysiology. Mount Kisco (NY): Futura Publishing Company, 1991: 41-7.

38. Maron BJ, Mitchell J. 26th Bethesda conference. Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Cardiol 1994; 24: 848-99.

39. Murgatroyd FD, O’Farrel D, Ward DE et al. Who gets paroxysmal atrial fibrillation? Clinical features in 222 patients from the Craft multi-centre registry. In: Olson SB, Allessie MA, Campbell RWF, eds. Atrial fibrillation mechanisms and novel therapeutic strategies. Proceedings of the abstracts. Lund; 1993: 7.

40. Epstein AE, Mile WM, Bendin DG et al. Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations. Circulation 1996; 94: 1147-66.

41. Coumel PR. Autonomic arrhythmogenic factors in paroxysmal atrial fibrillation. In: Olson SB, Allessie MA, Campbell RWF , eds. Atrial fibrillation mechanisms and therapeutic strategies. Armonk (NY): Futura Publishing Company, 1994: 171-85.

42. Furlanello F, Bertoldi A, Bettini R et al. Life-threatening tachyarrhythmias in athletes. PACE 1992; 15 (9): 1403-11.

43. Furlanello F, Bertoldi A, Dallago M et al. Atrial fibrillation in athletes. J Cardiovasc Electrophysiol 1998; 9: 563-8.

44. Bertoldi A, Furlanello F, Fernando F et al. Risk stratification in elite athletes with arrhythmias. Proceedings of the New Frontiers of Arrhythmias. 15th International Congress. Furlanello F, Bertoldi A, Cappato R, eds. GIAC 2002; 5: 218-9.

45. Cappato R, Negroni S, Furlanello F , et al. Efficacy of a probabilistic approach, step-wise RF catheter ablation approach for the curative treatment of atrial fibrillation. Proceedings of the New Frontiers of Arrhythmias 15th International Congress. GIAC 2002; 5: 281-2.

46. Wijffels MC, Kirchhof CJ, Dorland R et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1998; 92: 1954-68.

47. Bracchetti D, Naccarella F. Cuore e Sport. Linee guida per l’idoneità all’attività sportiva agonistica. Roma: Centro Scientifico Editore, 2002-2005.

48. Brembilla-Perrot B, Marçon F, Bosser G et al. Paroxysmal tachycardia in children and teenagers with normal sinus rhythm and without heart disease. PACE 2002; 24: 41-5.

49. Benson DW, Dunningan A, Benditt DG et al. Transesophageal study of infant with supraventricular tachycardia. Electrophysiologic characteristics. Am J Cardiol 1983; 52: 1002-6.

50. Brembilla-Perrot B, Spatz F, Khaaldi E et al. Value of esophageal pacing in evaluation of supraventricular tachycardia. Am J Cardiol 1990; 65: 322-30.

51. Brembilla-Perrot B, Terrier De La Chaise A, Pichenè M et al. Isoprenaline as an aid to the induction of cathecolamine-dependent supraventricular tachycardia as during programmed stimulation. Br Heart J 1989; 61: 348-55.

52. Slama R, Coumel Ph, Mottè G et al. Tachycardies paroxystiques liées à un syndrome de Wolff Parkinson White inapparent. Nouv Press Med 1975; 45: 169-72.

53. Garson A, Gillette PC. Electrophysiologic studies of supraventricular tachycardia in children. Prediction of specific mechanism by noninvasive features. Am Heart J 1981; 102: 383-8.

54. Biffi A, Ammirati F, Caselli G et al. Usefulness of transesophageal pacing during exercise for evaluation of palpitations in top-level athletes. Am J Cardiol 1993; 72: 922-6.

55. Pongiglione G, Saul P, Dunningan A et al. Role of transesophageal pacing in evaluation of palpitations in children and adolescents. Am J Cardiol 1988; 66: 566-70.

56. Driscoll DJ, Jacobsen SJ, Porter CNJ et al. Syncope in children and adolescents. Am J Cardiol 1997; 29: 1039-45.

57. Beder SD, Cohen MH, Riewenschneider TA. Occult arrhythmias as the etiology of unexplained syncope in children with structurally normal hearts. Am Heart J 1985; 109: 309-13.

58. Leitch JW, Klein GT, Yee R et al. Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response. Circulation 1992; 85: 1064-71.

59. Bayès de Luna A, Furlanello F, Maron BJ et al. Arrhythmias and sudden death in athletes. Dordrecht: Kluwer Academic Publishers, 2000.

60. Lin PH, Huang JL, Ting CT, Chen SA. Respiration and initiation of atrial fibrillation. J Cardiovasc Electrophysiol 2001; 12: 979.

61. Chou HH, Lin KH, Luqman N et al. Prolonged ventricular asystole, sinus arrest, and paroxysmal atrial flutter-fibrillation: an uncommon presentation of vasovagal syncope. PACE 2003; 26: 914-7.

62. Miyamoto KJ, Tsuchihasashi K, Uno K et al. Studies on the prevalence of complicated atrial arrhythmias, flutter and fibrillation in patients with reciprocating supraventricular tachycardia before and after successful catheter ablation. PACE 2001; 24: 969-78.

63. Taneja T, Windhagen Mahnert B, Passman R et al. Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults. PACE 2001; 24: 16-21.

64. ACC/AHA/ESC. Management of patients with atrial fibrillation. Pocket Guidelines, 2002; 1-75.

65. ACC/AHA/ESC. Guidelines for the management of patients with atrial fibrillation: executive summary. Guidelines Executive Summary, 2001.

66. Comitato organizzativo cardiologico per l’idoneità allo sport (ANCE-ANMCO-FMSI-SIC-SIC SPORT). Protocolli cardiologici per il giudizio di idoneità allo sport agonistico. Roma: Casa Editrice Internazionale, 1995: 1-75.

67. Comitato organizzativo cardiologico per l’idoneità allo sport (ANCE-ANMCO-FMSI-SIC-SIC SPORT). Protocolli cardiologici per il giudizio di idoneità allo sport agonistico. Roma: Casa Editrice Internazionale, 2003: 430-7.

68. Fenici RR, Brisinda D, Fenici P et al. La sindrome da pre-eccitazione cardiaca e l’ablazione transcatetere delle aritmie. In: Zeppilli P. Cardiologia dello sport. Roma: Casa Editrice Scientifica Internazionale, 2001.

69. Zeppilli P. Cardiologia dello sport. Roma: Casa Editrice Scientifica Internazionale, 2003.

70. Brugada R, Roberts R. Familial atrial fibrillation. In: Berul CL, Towbin JA, eds. Molecular genetics of cardiac electrophysiology. Norwell (MA): Kluwer Academic Publishers, 2000: 90-8.

71. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469-73.

72. Wolff L. Familial auricular fibrillation. N Engl J Med 1943; 229: 396-7.

73. Poret P, Mabo P, Deplace C et al. Isolated atrial fibrillation genetically determined? Apropos of a familial history. Arch Mal Coeur Vaiss 1996; 89: 1197-203.

74. Beyer F, Luhmer PT, Bertram H et al. Familial idiopathic atrial fibrillation with bradyarrhythmia. Z Kardiol 1993; 82: 674-7.

75. Brugada R, Bachinski LL, Hill R et al. Familial atrial fibrillation is a genetically heterogeneous disease. J Am Coll Cardiol 1998; 31: 349A.

76. Berul CI, Towbin JA. Molecular genetics of cardiac electrophysiology. Norwell (MA): Kluwer Academic Publishers, 2000: 1-201.

77. Mark Estes III NA, Salem DN, Wang PJ. Sudden cardiac death in the athlete. Armonk (NY): Futura Publishing Co, 1999.

78. Palmieri M, Bracchetti D. Il paziente con fibrillazione atriale. In: Palmieri M, Bracchetti D. Atti del Convegno di Aggiornamento in Cardiologia dello Sport, 2002: 69-78.

79. Palmieri M, Bracchetti D. Atti del Convegno di Aggiornamento in Cardiologia dello Sport, 2002: 1-203.

80. Karch MR, Ndrepepa G, Schneider MAE et al. Single chamber atrial fibrillation involving only the left atrium: implications for maintenance and radiofrequency ablation therapy. PACE 2003; 26: 883-91.

81. Schweikert RA, Lugones AP, Kanagaratnam L et al. A simple method of mopping atrial premature depolarization triggering atrial fibrillation. PACE 2001; 24: 22-7.

82. Wang TD, Chen WJ, Su SS et al. Increased levels of tissue plasminogen activator antigen and factor VIII activity in nonvalvular atrial fibrillation: relation to predictors of thromboembolism. J Cardiovasc Eclectrophisiol 2001; 12: 877-84.

83. Schuessler RB. Does size matter? J Cardiovasc Electrophysiol 2001; 12: 875-6.

84. Santini M. Non pharmacological treatment of atrial fibrillation Arianna Editrice. 1-325; 2002.

85. Lau CP, Tse HF Early reinitiation of atrial fibrillation after electrical defibrillation: a new electrophysiological phenomenon. PACE 2001; 24: 1581-82.

86. Maounis T, Kyrozi E, Katsaros K et al. The prognostic significance of atrial arrhythmias recorded early after cardioversion for atrial fibrillation. PACE 2000; 24: 1076-1081.

87. Wu TJ, Doshi RN, Huang HL et al. Simultaneous biatrial computerized mapping during permanent atrial fibrillation in patients with organic heart disease. J Cardiovasc Electrophysiol 2002; 13: 571-7.

88. Erdogan A, Carlsson J, Neumann T et al. Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up. PACE 2001; 26: 678-84.

89. Leclercq JF, De Sisti A, Fiorello P et al. Is dual better than single site atrial pacing in the prevention of atrial fibrillation? PACE 2000; 23: 2101-7.

90. De Ambroggi L. Atrial Fibrillation in 2000 Electrocardiology. Proceedings of the XXVII International Congress in Electrocardiology. 2002 Jun 27- Jul 1, Milan.

91. Furlanello F, Cappato R, De Ambroggi L. Evaluation of the arrhythmic athlete. Proceedings of the one day workshop. 2003 Mar 3; Milan.

92. Atrial fibrillation and arrhythmic syndromes. In: Atti del Convegno “Esperienze a confronto” II giornata livornese di Medicina dello Sport; 2003 Mag 30-31; Livorno, Italia.

93. Furlanello F. Atrial fibrillation. Proceedings of the Italian Congress of the SIC SPORT. Montecatini; 2003 Giu 16-17; 1-96.

94. Naccarella F. Dati preliminari del registro prospettico italiano RETE MIDAS-Medtronic. “Fibrillazione atriale ed aritmie negli atleti di calcio e basket”. Milano 3/3/2003.

95. Furlanello F, Fernando F, Galassi A, Bertoldi A. Ventricular arrhythmias in apparently healthy athletes. In: Malik M, ed. Risk of arrhythmia and sudden death. London: BMJ Books, 2001: 316-24.

96. Furlanello F, Bertoldi A, Galassi A et al. Management of severe cardiac arrhythmic events in elite athletes. PACE 1999; 22: A 165.

97. Furlanello F, Bertoldi A, Dallago M et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 1998; 98 (Suppl): 563-8.

98. Furlanello F, Bertoldi A, Fernando F et al. Competitive athletes with arrhythmias. Classification, evaluation and treatment. In: Bayes de Luna A, Furlanello F, Maron B.J et al, eds. Arrhythmias and sudden death in athletes. Dordrecht: Kluwer Academic Publishers; 2000: 7, 89-105.

99. Furlanello F, Bertoldi A, Dallago M, et al: Atrial fibrillation in top-level athletes, In Olsson SB, Allessie MA, Campbell RWF, eds: Atrial fibrillation: mechanisms therapeutic strategies. Armonk (NY): Futura Publishing Company, 1994: 203-4.

100. Furlanello F, Bentivegna S, Cappato R et al. Arrhythmogenic effects of illicit drugs in athletes. Ital Heart J 2003; 4(12): 829-37.

101. Martini B, Nava A. 1988-2003. Fifteen years after the first Italian description by Nava-Martini-Thiene and colleagues of a new syndrome (different from the Brugada syndrome?) in the Giornale Italiano di Cardiologia: do we really know everything on this entity? Ital Heart J 2004; 5(1): 53-60.

102. Osher HL, Wolff L. Electrocardiographic pattern simulating acute myocardial injury. Am J Med Sci 1953; 226: 541-5.

103. Calo AA et al. The triad secondary R wave, RS-T segment elevation and T waves inversion in right precordial leads: a normal electrocardiogram variant. G Ital Cardiol 1975; 5: 955-60.

104. Vatta M, Dumaine R, Varghese G et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002; 11: 337-45.

105. Martini B, Nava A, Thiene G et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989; 116: 1203-9.

106. Brugada P, Brugada J. A distinct clinical and electrocardiographic syndrome: right bundle branch block, persistent ST segment elevation with normal QT interval and sudden death. PACE 1991; 14: 746.

107. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 1992; 20: 1391-6.

108. Sumiyoshi M, Nakata Y, Hisaoka T. A case of idiopathic ventricular fibrillation with incomplete right bundle branch block and persistent ST segment elevation. Jpn Heart J 1993; 34: 661-6.

109. Proclemer A, Facchin D, Feruglio GA et al. Fibrillazione ventricolare recidivante, blocco di branca destra, persistente sopraslivellamento del tratto ST in V1-V3: una nuova sindrome aritmica? G Ital Cardiol 1993; 23: 1211-8.

110. Naccarella F et al. Malignant ventricular arrhythmias in patients with a right bundle branch block and persistent ST elevation in V1- V3. A probable arrhythmogenic cardiomyopathy of the right ventricle. G Ital Cardiol 1993; 23: 1219-22.

111. Martini B, Nava A, Canciani B et al. Right bundle branch block, persistent ST segment elevation and sudden cardiac death. J Am Coll Cardiol 1993; 22: 633.

112. Brugada P, Brugada J. Do not get confused, please. G Ital Cardiol 1993; 22: 635.

113. Bjerregaard P, Grussak I, Kotar SL et al. Recurrent syncope in a patient with prominent J wave. Am Heart J 1994; 127: 1426-30.

114. Tada H, Aihara N, Ohe T et al. New insights in idiopathic ventricular fibrillation patients with right precordial leads ST segment elevation. Circulation 1995; 4: 281.

115. D’ Onofrio A, Cuomo S, Musto B et al. Right bundle branch block, persistent ST segment elevation in V1 V3 and sudden death: always a distinct syndrome ? G Ital Cardiol 1995; 25: 1171-5.

116. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 1996; 93: 372-9.

117. Kobayashi T, Shintani U, Yamamoto T et al. Familial occurrence of electrocardiographic abnormalities of the Brugada-type. Intern Med 1996; 35: 637-40.

118. Naccarella F, Sdringola Maranga S, Capone D et al. Caratteristiche cliniche, distribuzione familiare e preliminari dati genetici in nove famiglie con “sindrome di Brugada”. G Ital Cardiol 1999; 29: 1488-95.

119. Naccarella F, Lepera G, Maranga S et al. The Martini-Brugada syndrome. Clinical evaluation, follow up and genetic screening of nine families. Journal of MESPE 2001; 2: 34-46.

120. Antzelevitch C, Brugada P, Brugada J et al. The Brugada syndrome. Armonk (NY): Futura Publishing Company, 1999.

121. Miyazaki T, Mitamura H, Miyoshi S et al. Autonomic and antiarrhythmic modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-70.

122. Shimada M, Miyazaki T, Miyoshi S et al. Sustained monomorphic ventricular tachycardia in a patient with Brugada syndrome. Jpn Circ J 1996; 60: 364-70.

123. Antzelevitch C, Brugada P, Brugada J et al. Brugada syndrome: a decade of progress. Circ Res 2002; 91: 1114-8.

124. Antzelevitch C, Brugada P, Brugada J et al. Brugada Syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 2003; 41: 1665-71.

125. Priori SG, Aliot C, Blomstrom-Lunqvist C et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2002; 22: 1374-450.

126. Hauer RN, Aliot E, Block M et al. Indicazioni alla terapia con defibrillatore impiantabile (ICD). Eur Heart J 2001; 22: 1074-81.

127. Bezzina C, Veldkamp MW, Van den Berg MP et al. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999; 85: 1206-13.

128. Priori SG, Napolitano C, Schwartz PJ et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 2002; 102: 945-7.

129. Naccarella F, Lepera G, Maranga S. Clinical noninvasive-invasive evaluation and five years follow up in patients with the Brugada syndrome. A prospective Excel-Access database. Proceedings of the American College of Cardiology Scientific Sessions; 2002; Atlanta.

130. Towbin JA, Vatta M, Nademanee K et al. In: Molecular genetics of cardiac electrophysiology. Berul CI, Towbin JA, eds. Norwell (MA): Kluwer Academic Publishers, 2002: 1-234.

131. Weiss R, Barmada MM, Nguyen T et al. Clinical and molecular heterogeneity in the Brugada Syndrome. A Novel Gene Locus on Chromosome 3. Circulation 2002; 105: 707-13.

132. Brugada J, Brugada R, Antzelevitch C et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105: 73-8.

133. Priori SG, Napolitano C, Gasparini M et al. Natural history of Brugada syndrome. Insights for risk stratification and management. Circulation 2002; 105: 1342-7.

134. Leoni L, Delise P, Bertaglia E, Fantinel M et al. Follow-up a lungo termine di soggetti con aspetto ECG di ripolarizzazione precoce in sede precordiale destra (simil Brugada). Studio multicentrico. Atti del 63 Congresso Nazionale SIC; 2002 dic 14-18; Roma, Italia.

135. Corrado D, Nava A, Buja G et al. Familial cardiomyopathies underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996; 27: 443-8.

136. Ohe T. Idiopathic ventricular fibrillation of the Brugada type: an atypical form of arrhythmogenic right ventricular cardiomyopathy? Intern Med 1996; 35: 595.

137. Fontaine G. Familial cardiomyopathy associated with right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996; 28: 540-1.

138. Naccarella F. Clinical, non invasive evaluation and 5 year follow-up in patients with the Brugada syndrome. A prospective access data base in Bologna. Ann Non Invas Electrocardiol 2002; 857-5.

139. Naccarella F, Naccarelli GV, Sdringola Maranga S et al. Comparative evaluation of imaging techniques (Echo, NMR ventriculography and others) in subjects with Brugada syndrome, right ventricular dysplasia cardiomyopathy and normal hearts. New Frontiers of Arrhythmias 2002. Proceedings of the 15 International Congress; 2002.

140. Tagaki M, Aikara N, Taguchi A. Localized right ventricular morphological abnormalities in patients with Brugada syndrome by ultrafast computed tomography and magnetic resonance imaging. Is Brugada syndrome truly idiopathic? Circulation 1998; 848.

141. Wilde A, Antzelevitch C, Borggrefe M et al. Study group on the molecular basis of arrhyhmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002; 106: 2514-9.

142. Riemann R, Matheja P, Witcher T et al. Locally reduced cardiac 1-123. MIBG uptake in Brugada syndrome, 5th International Conference of Nuclear Cardiology (ICNC5); 2001 mag 2-5; Vienna.

143. Witcher T, Matheja P, Eckardt L et al. Cardiac autonomic dysfunction in Brugada Syndrome. Circulation 2002; 105: 702-6.

144. Naccarelli GV, Antzelevitch C, Naccarella F et al. The Brugada syndrome: clinical diagnosis and treatment. Current Opinion in Cardiology 2002; 23: 14-27.

145. Chinushi M, Aizawa Y et al. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol 1997; 30: 133-4.

146. Chen Q, Kirsh GE, Zhang D et al. Genetic basis and molecular mechanisms for idiophatic ventricular fibrillation. Nature 1998; 392: 293-6.

147. Nakamura W, Segawa K et al. Class I C antiarrhythmic agents, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. J Cardiovasc Electrophysiol 1998; 9: 855-8.

148. Naccarella F, Naccarelli GV, Sdringola Maranga S et al. Provocative drug testing in Brugada syndrome family members: background, methodology and personal experience. Ital Heart J 2004; 5 (Suppl 1): 186-92.

149. Makita N, Shirai N et al. Mutant cardiac Na+ channel alpha subunit (TI620M) of an idiophatic ventricular fibrillation family exhibits altered functional association with beta1 subunit. Circulation 1998; 275.

150. Ikeda T, Sakata T et al. Noninvasive risk stratification markers in the Brugada syndrome. Comparison of late potentials, T wave alternans and QT dispersion. PACE 2000; 23: 731.

151. Ikeda T, Sakurada H, Sakabe K et al. Assessment of non invasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001; 37: 1628-34.

152. Priori SG, Gasparini M, Napoletano C et al. Clinical and genetic heterogeneity of the right bundle branch block and ST segment elevation syndrome. A prospective evaluation of 52 families. Circulation 2000; 102: 2509-15.

153. Nishizaki M, Sakurada H, Ashikaga T et al. Effect of insulin on ST segment elevation in Brugada syndrome. Circulation 2000; 102: 585-6.

154. Gussak I, Hammil SC. Clinical diagnosis and risk stratification in patients with Brugada syndrome. J Am Coll Cardiol 2001; 37: 1635-8.

155. Vatta M, Dumnaine R, Varghese G et al. Genetic screening and biophysical basis of sudden death unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002; 11: 337-45.

156. Perez Riera AR, Schapachnik E. Virtual symposium about Brugada syndrome: ten years of history: 1992-2002. http://www.brugada-symposium.org/2002.

157. Atarashi H, Ogawa S et al. For the idiopathic ventricular fibrillation investigators. New ECG criteria for high risk Brugada Syndrome. Circ J 2003; 67: 8-10.

158. Rabinovich A. All programmed ventricular stimulation in Brugada disease. Forum of the First Virtual Symposium about Brugada syndrome. Proposed criteria. http://www.brugada-symposium.org/2002.

169. Wichter T, Matheja P, Eckardt L et al. Cardiac autonomic dysfunction in Brugada Syndrome. Circulation 2002; 105: 702-6.

170. Naccarella F, Sdringola Maranga S. Role of programmed electrical stimulation in other clinical conditions than coronary artery disease and post AMI CAD (Arrhythmogenic right ventricular dysplasia, long QT interval, Brugada syndrome, cathecolaminergic polimorphous VT). In: Raviele A, ed. Proceedings of the V International Congress on Arrhythmias; 2002; Venezia, Italia. Milan: Springer Verlag, 2003: 24-35.

161. Aguinaga L. Sindrome de Brugada. Edicion latina de Electrocardiologia 2002; 8: 2-12.

162. Naccarella F, Naccarelli GV, Fattori R et al. Arrhythmogenic right ventricular dysplasia cardiomyopathy: current opinions on diagnostic and therapeutic aspects. Cardiol 2001; 16: 8-16.

163. Marcus F, Calkins H. Multidisciplinary study of right ventricular dysplasia. US Multicentric DATABASE 2000.

164. Marcus FI, Ott P. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Molecular genetics of cardiac electrophysiology 2002; 31; 146-167.

165. Perez Riera AR, Schapachnik E. List of related entities and diseases with a secondary BP that eventually show differential diagnosis with the Brugada disease. Forum of the First Virtual Symposium about Brugada Syndrome. http://www.brugada-symposium.org/2003.

166. Perez Riera AR, Schapachnik E. Differences between Brugada disease and cathecolaminergic polymorphic ventricular tachycardia. Forum of the First Virtual Symposium about Brugada Syndrome. http://www.brugada-symposium.org/2003.

167. Perez Riera AR, Fortunato de Cano, Fleury de Padua Neto LA et al. Sindrome de Brugada: nuevos conceptos y expectivas futures. Rev Argent Cardiol 2001; 69: 652-62.

168. Perez Riera AR, Schapachnik E, Ferreira C. Historical review. Brugada disease; chronology of discovery and paternity. Preliminary observations and historical aspects. Indian Pacing Electrophysiology 2003; 3(4): 253-66.

169. Ilz B, Luft FC. Acquired Brugada syndrome. Am J Cardiol 2003; 92 (6): 771-7.

170. Gaita F, Giustetto C, Bianchi Wolpèrt C et al. Short QT sindrome a familial cause of sudden death. Circulation 2003; 108 (8) 965-70.

171. Naccarella F, Naccarelli GV, Sdringola Maranga S et al. Brugada syndrome or Brugada Pattern? An historical and critical review of what we should call today: Brugada disease. Curr Opin Cardiol 2004; 2 (3): 24-46.

172. Haissaguerre M, Jais P, Shah D et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66.

173. Jais P, Haissaguerre M, Shah D et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-6.

174. Chen SA, Hsieh MH, Tai CT et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effect of radiofrequency ablation. Circulation 1999; 100: 1879-86.

175. Haissaguerre M, Jais P, Shah D et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-17.

176. Haissaguerre M, Shah D, Jais P et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102(20): 2463-5.

177. Oral H, Knight BP, Tada H et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-81.

178. Marrouche NF, Dresing NF, Cole CR et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter techniques. J Am Coll Cardiol 2002; 40: 464-74.

179. Tai CT, Hsieh MH, Tsai CF et al. Differentiating the ligament of Marshall from the pulmonary vein musculature potentials in patient with paroxysmal atrial fibrillation: electrophysiological characteristics and results of radiofrequency ablation. Pacing Clin Electrophysiol 2000; 23: 1493-501.

180. Shah D, Haissaguerre M, Jais P et al. Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients: strategy for presentation ranging from sustained atrial fibrillation to no arrhythmia. J Cardiovasc Electrophysiol 2001; 10: 1541-58.

181. Goya M, Ouyang F, Ernst S et al. Electroanatomic mapping and catheter ablation of breakthroughs from the right atrium to the superior vena cava in patients with atrial fibrillation. Circulation 2002; 106: 1317-20.

182. Pappone C, Oreto G, Lamberti F et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999; 100: 1203-8.

183. Corrado D, Leoni L, Link M et al. Implantable Cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003; 108: 3084-91.

184. Naccarella F, Naccarelli GV, Fattori R et al. Arrhythmogenic right ventricular dysplasia-cardiomyopathy: diagnostic and therapeutic aspects. Current opinion in Cardiology 2003; 16: 8-18

185. Naccarella F, Bresciani B, Liying C et al. Valutazione clinica e prospettica di 13 portatori di sindrome di Brugada e delle loro famiglie. Atti del Congresso Clinica delle aritmie; 2005; Bologna.